Full-Time

Administrative Lead

Posted on 8/23/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

No salary listed

Senior

Somerset County, NJ, USA

Flexibility to work in all three NJ offices as required.

Category
Executive Support
Administrative & Executive Assistance
Administrative Support
Specialized Administrative Roles
Scheduling & Travel Coordination
Required Skills
SAP Products
Requirements
  • Bachelor’s degree in Business Administration, Management, or a related field preferred.
  • A minimum of 5 years of administrative experience, including at least 2 years in a supervisory role. Preferably, the candidate should also have experience in a fast paced professional environment, working with cross-functional teams, and supporting multiple sites.
  • Strong proficiency in Microsoft Office Suite (Word, Excel, PowerPoint, Outlook).
  • Experience with SAP or similar enterprise resource planning (ERP) systems.
  • Exceptional organizational and time management skills.
  • Excellent communication and interpersonal skills.
  • Ability to handle sensitive information with confidentiality and discretion.
Responsibilities
  • Supervise a team consisting of two Administrative Assistants and one Office Administrator, providing guidance, support, and performance management to ensure team effectiveness.
  • Support and assist C-level executives with their administrative needs.
  • Manage and coordinate departmental day-to-day activities, including travel arrangements, expense reports, email correspondence, calendars, meeting planning, and preparation.
  • Manage various administrative duties including arranging catering, maintaining excellent vendor relations, and acting as a point of contact for internal and external stakeholders.
  • Coordinate complex domestic and international travel arrangements and prepare expense reports and reimbursement requests.
  • Assist in coordinating special events and projects, including monthly meetings, corporate-wide gatherings, and giveaways.
  • Complete necessary documents to set up new suppliers in the system, create purchase orders, and approve invoices in SAP.
  • Make purchases on behalf of various departments and liaise closely with Finance and Procurement to reconcile the corporate credit card and submit financial documents in a timely manner.
  • Establish and maintain effective working relationships with company executives, staff, and key business partners.
  • Assist with planning and executing departmental events such as holiday events, farewells, and team-building activities.
  • Assist with preparing departmental presentations, tables, charts, and other information using PowerPoint, Excel, and other technology.
  • Flexibility to work in all three NJ office as required.

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers affecting the blood and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company focuses on personalized medicine, which means they tailor therapies to individual patients. They not only discover and develop new treatments but also bring them to market, generating revenue through licensing and sales of their therapies, including CAR-T therapies that modify patients' own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial performance and business developments. Their goal is to provide effective treatments for hard-to-treat diseases.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Franklin Township, New Jersey

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • $150M investment in Belgium facility shows commitment to expanding production capabilities.
  • Alan Bash's appointment strengthens leadership in CAR-T therapy market.
  • New R&D facility in Philadelphia focuses on next-generation cell therapies.

What critics are saying

  • Increased competition from Amgen's Imdelltra could impact market share.
  • Collaboration with Multiply Labs may face challenges in scaling up production.
  • Expansion of R&D facilities requires significant investment, potentially straining resources.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective treatments.
  • Legend Biotech's business model includes discovery, development, and commercialization of therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

0%

2 year growth

0%
Fierce Pharma
Mar 12th, 2025
J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms

J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms.

The Yellow Brick Road
Mar 3rd, 2025
YB new stock pitches (Mon, Mar 3)

Legend Biotech Corporation (LEGN) is developing a promising CAR-T cancer drug in partnership with Johnson & Johnson.

ROI-NJ
Nov 5th, 2024
Legend Biotech Names Alan Bash As Leader Of Its Cer-T Product

Legend Biotech Corporation on Tuesday said it appointed Alan Bash as president of its CAR-T product CARVYKTI®. In this newly created role, Bash will be responsible for managing the continued growth of CARVYKTI®, overseeing the Somerset-based firm’s commercial, technical operations, and quality functions of the franchise.“This expansion in our leadership structure is on the heels of CARVYKTI’s recent successes, including recent approvals from the U.S. Food and Drug Administration and European Commission for label expansion,” Ying Huang, chief executive officer of Legend Biotech said. “Legend Biotech welcomes Alan and is confident that his wealth of operational knowledge in oncology will help further strengthen the Company’s leadership role in the treatment of multiple myeloma.”Previously, Bash served as chief executive officer for two oncology-focused biotech companies, most recently at ZielBio, and before that, as president and CEO at Checkmate Pharmaceuticals. He also had a 23-year career with Bristol Myers Squibb, where he held various leadership positions across all major therapeutic areas—including oncology—driving the U.S. launch of Opdivo® and the expansion of additional cancer treatments such as Yervoy® and Erbitux ®.Bash contributed to several blockbuster products in collaboration with other companies, including Abilify® with Otsuka and Eliquis® with Pfizer.“As the fastest launched CAR-T product on the market, CARVYKTI has already produced impressive momentum,” Bash said

GlobeNewswire
Nov 4th, 2024
Legend Biotech Appoints Alan Bash As President Of Carvykti(R)

SOMERSET, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Alan Bash as the Company’s President of CARVYKTI®. In this newly created role, Mr. Bash will be responsible for managing the continued growth of CARVYKTI®, overseeing Legend Biotech’s commercial, technical operations, and quality functions of the franchise.“This expansion in our leadership structure is on the heels of CARVYKTI’s recent successes, including recent approvals from the U.S. Food and Drug Administration and European Commission for label expansion,” said Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech. “Legend Biotech welcomes Alan and is confident that his wealth of operational knowledge in oncology will help further strengthen the Company’s leadership role in the treatment of multiple myeloma.”Mr

BioBuzz
Oct 30th, 2024
Legend Biotech Chooses Philadelphia for New R&D Center

With a global workforce of 1,500 employees, including 350 in R&D, Legend is expanding its manufacturing capabilities with new facilities in New Jersey and beyond.

INACTIVE